Arsenic toxicity is enzyme specific and its affects on ligation are not caused by the direct inhibition of DNA repair enzymes

被引:141
作者
Hu, Y
Su, L
Snow, ET
机构
[1] NYU, Med Ctr, Nelson Inst Expt Med, Tuxedo, NY 10987 USA
[2] NYU, Med Ctr, Kaplan Comprehens Canc Ctr, Tuxedo, NY 10987 USA
来源
MUTATION RESEARCH-DNA REPAIR | 1998年 / 408卷 / 03期
关键词
arsenic toxicity; DNA ligase activity; DNA repair enzyme;
D O I
10.1016/S0921-8777(98)00035-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
The molecular mechanism of arsenic toxicity is believed to be due to the ability of arsenite [As(III)] to bind protein thiols. Numerous studies have shown that arsenic is cytotoxic at micromolar concentrations. Micromolar As can also induce chromosomal damage and inhibit DNA repair. The mechanism of arsenic-induced genotoxicity is very important because arsenic is a human carcinogen, but not a mutagen, and there is a need to establish recommendations for safe levels of As in the environment. We have measured the dose-response for arsenic inhibition of several purified human DNA repair enzymes, including DNA polymerase beta, DNA ligase I and DNA ligase III and have found that most enzymes, even those with critical SH groups, are very insensitive to As. Many repair enzymes are activated by millimolar concentrations of As(III) and/or As(V). Only pyruvate dehydrogenase, one of eight purified enzymes examined so far, is inhibited by micromolar arsenic. In contrast to the purified enzymes, treatment of human cells in culture with micromolar arsenic produces a significant dose-dependent decrease in DNA ligase activity in nuclear extracts from the treated cells. However, the ligase activity in extracts from untreated cells is no more sensitive to arsenic than the purified enzymes. Our results show that direct enzyme inhibition is not a common toxic effect of As and that only a few sensitive enzymes are responsible for arsenic-induced cellular toxicity. Thus, arsenic-induced co-mutagenesis and inhibition of DNA repair is probably not the result of direct enzyme inhibition, but may be an indirect effect caused by As-induced changes in cellular redox levels or alterations in signal transduction pathways and consequent changes in gene expression. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:203 / 218
页数:16
相关论文
共 83 条
[1]
INHIBITION OF PYRUVATE-DEHYDROGENASE MULTIENZYME COMPLEX FROM ESCHERICHIA-COLI WITH A RADIOLABELED BIFUNCTIONAL ARSENOXIDE - EVIDENCE FOR AN ESSENTIAL HISTIDINE RESIDUE AT THE ACTIVE-SITE OF LIPOAMIDE DEHYDROGENASE [J].
ADAMSON, SR ;
ROBINSON, JA ;
STEVENSON, KJ .
BIOCHEMISTRY, 1984, 23 (06) :1269-1274
[2]
DNA repair and its regulatory pathways in cancer pharmacology [J].
AlaouiJamali, M ;
Mitra, S .
M S-MEDECINE SCIENCES, 1996, 12 (6-7) :766-773
[4]
BERGELSON S, 1994, CANCER RES, V54, P36
[5]
EFFECT OF POLYVALENT METAL-IONS ON THE REACTIVITY OF HUMAN O6-METHYLGUANINE-DNA METHYLTRANSFERASE [J].
BHATTACHARYYA, D ;
BOULDEN, AM ;
FOOTE, RS ;
MITRA, S .
CARCINOGENESIS, 1988, 9 (04) :683-685
[6]
SELECTIVE INACTIVATION OF TRANSACYLASE COMPONENTS OF 2-OXO ACID DEHYDROGENASE MULTIENZYME COMPLEXES OF ESCHERICHIA-COLI [J].
BROWN, JP ;
PERHAM, RN .
BIOCHEMICAL JOURNAL, 1976, 155 (02) :419-&
[7]
Byrd DM, 1996, INT ARCH OCC ENV HEA, V68, P484
[8]
The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase [J].
Cavigelli, M ;
Li, WW ;
Lin, AN ;
Su, B ;
Yoshioka, K ;
Karin, M .
EMBO JOURNAL, 1996, 15 (22) :6269-6279
[9]
Inhibition by arsenite of anticancer drug cis-diamminedichloroplatinum (II) induced DNA repair and drug resistance in HeLa cells [J].
Chao, CCK .
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 1996, 1 (03) :199-205
[10]
Chen GQ, 1997, BLOOD, V89, P3345